Biocon Q4 net dips 54 pc at Rs 113 crore

Biotechnology major Biocon today reported a 54.51 per cent decline in its consolidated net profit at Rs 113.08 crore for the fourth quarter ended March 31, 2014.

The company had posted a net profit of Rs 248.61 crore in the same period of the previous fiscal.

Net sales of the company rose to Rs 722.59 crore for the fourth quarter as against Rs 630.12 crore for the same period a year ago, Biocon Ltd said in a statement.

For the year ended March 31, 2014, the company's net profit declined by 18.69 per cent to Rs 413.72 crore from Rs 508.82 crore in the 2012-13 fiscal.

The company's net sales for the just-concluded fiscal rose to Rs 2,852.72 crore, as against Rs 2,427.60 crore in the previous year.

In a separate statement, the Bangalore-based firm said it has appointed Arun Chandavarkar as the Chief Executive Officer and Joint Managing Director.

The company's board also recommended a final dividend of Rs 5 per share (100 per cent) for the FY 2013-14.

Biocon shares were trading at Rs 481.10 apiece on the BSE, up 3.04 per cent from its previous close.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • The survey paints an optimistic future, but sees little scope for a bang

    The Economic Survey, which comes out a day before the Union budget, is widely regarded as its forerunner, an indicator of things to come 24 hours late

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Urs Schoettli

The hidden attractions of Japan

We live in the Asian century. During the past two ...

Zehra Naqvi

Star power

Being a part of the generation that gorged on Shah ...

Bubbles Sabharwal

The waking moment decides the day

There was a little girl/ Who had a little curl/ ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture